| Title | Pharmacogenomics and Personalized Medicine |
| Abbreviation | Pharmacogenomics Pers. Med. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (Q2); Molecular Medicine (Q3) |
| h-index | 40 |
| Overall Rank/Ranking | 8473 |
| SCImago Journal Rank (SJR) | 0.675 |
| Impact Score | 1.85 |
| Publisher | Dove Medical Press Ltd |
| Country | New Zealand |
| ISSN | 11787066 |
| Best Quartile | Q2 |
| Coverage History | 2009-2025 |
Pharmacogenomics and Personalized Medicine is a journal covering the technologies/fields/categories related to Pharmacology (Q2); Molecular Medicine (Q3). It is published by Dove Medical Press Ltd. The overall rank of Pharmacogenomics and Personalized Medicine is 8473. According to SCImago Journal Rank (SJR), this journal is ranked 0.675. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 40. The best quartile for this journal is Q2.
The ISSN of Pharmacogenomics and Personalized Medicine journal is 11787066. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pharmacogenomics and Personalized Medicine is cited by a total of 674 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Pharmacogenomics and Personalized Medicine is 1.85, which is computed in 2025 as per its definition. Pharmacogenomics and Personalized Medicine IF is decreased by a factor of 0.09 and approximate percentage change is -4.64% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Pharmacogenomics and Personalized Medicine is 1.85. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.85 |
| 2023 | 1.94 |
| 2022 | 1.87 |
| 2021 | 2.60 |
| 2020 | 3.96 |
| 2019 | 3.72 |
| 2018 | 3.20 |
| 2017 | 3.93 |
| 2016 | 4.75 |
| 2015 | 4.46 |
| 2014 | 3.41 |
Pharmacogenomics and Personalized Medicine has an h-index of 40. It means 40 articles of this journal have more than 40 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Pharmacogenomics and Personalized Medicine is 11787066. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Pharmacogenomics and Personalized Medicine is 8473. According to SCImago Journal Rank (SJR), this journal is ranked 0.675. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.675 |
| 2023 | 0.508 |
| 2022 | 0.469 |
| 2021 | 0.683 |
| 2020 | 0.845 |
| 2019 | 0.967 |
| 2018 | 0.965 |
| 2017 | 1.353 |
| 2016 | 1.208 |
| 2015 | 1.195 |
| 2014 | 0.901 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8473 |
| 2023 | 10625 |
| 2022 | 10938 |
| 2021 | 7089 |
| 2020 | 5608 |
| 2019 | 4549 |
| 2018 | 4589 |
| 2017 | 2736 |
| 2016 | 3326 |
| 2015 | 3440 |
| 2014 | 4989 |
Pharmacogenomics and Personalized Medicine is published by Dove Medical Press Ltd. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2009-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Pharmacogenomics and Personalized Medicine is Pharmacogenomics Pers. Med.. This abbreviation ('Pharmacogenomics Pers. Med.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (Q2); Molecular Medicine (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Pharmacogenomics and Personalized Medicine latest impact IF is 1.85. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.75 (2016) and 1.85 (2024), respectively, in the last 11 years. Moreover, its average IS is 3.24 in the previous 11 years.
The Pharmacogenomics and Personalized Medicine has an SJR (SCImago Journal Rank) of 0.675, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.353 in 2017 and the lowest being 0.469 in 2022. Furthermore, the average SJR of the Pharmacogenomics and Personalized Medicine over the previous 11-year period stands at 3.24.
The latest h-index of the Pharmacogenomics and Personalized Medicine is 40.
The Pharmacogenomics and Personalized Medicine is published by the Dove Medical Press Ltd, with its country of publication being the New Zealand.
The Pharmacogenomics and Personalized Medicine is currently ranked 8473 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2736 in 2017 and its lowest position of 10938 in 2022.
The standard ISO4 abbreviation for the Pharmacogenomics and Personalized Medicine is Pharmacogenomics Pers. Med..
Pharmacogenomics and Personalized Medicine is classified as a journal that the Dove Medical Press Ltd publishes.
The Pharmacogenomics and Personalized Medicine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Pharmacogenomics and Personalized Medicine is assigned the following International Standard Serial Numbers (ISSN): 11787066.
The best quartile for the Pharmacogenomics and Personalized Medicine is Q2 (2024).
The Pharmacogenomics and Personalized Medicine coverage history can be summarized as follows: 2009-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Field Archaeology | journal | 7683 | Maney Publishing | 48 | 1.85 |
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Milan Journal of Mathematics | journal | 5131 | Birkhauser Verlag Basel | 31 | 0.74 |
| Discourse | journal | 7536 | Routledge | 70 | 2.75 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Journal of Education and Work | journal | 8987 | Brill Academic Publishers | 47 | 2.08 |
| Educational Measurement: Issues and Practice | journal | 6760 | Wiley-Blackwell Publishing Ltd | 68 | 1.54 |
| Tekstilec | trade journal | 17340 | University of Ljubljana Press | 16 | 1.29 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.85 |
| 2023 | 1.94 |
| 2022 | 1.87 |
| 2021 | 2.60 |
| 2020 | 3.96 |
| 2019 | 3.72 |
| 2018 | 3.20 |
| 2017 | 3.93 |
| 2016 | 4.75 |
| 2015 | 4.46 |
| 2014 | 3.41 |
